News

The study aims to uncover whether the medication dapagliflozin can prevent serious health complications such as heart attacks, strokes, or kidney failure. This collaborative project brings together le ...

 The discussions revealed illuminating insights into the increasing complexity of diabetes management, particularly around early-onset type 2 diabetes, emerging therapies and the need for enhanced mul ...

Diabetes Professional Care opened its doors on 21-22 October 2024 at Olympia London to 2,400+ professionals across primary and secondary care who gathered to discuss the latest developments in treatin ...

Initially sceptical about the power of a pump, Marcus Bosano explains how he ended up moving to Omnipod® and not looking back.

This article has been written and funded by AstraZeneca. AstraZeneca has provided sponsorship funding towards the DPC programme but has had no input into the content other than AstraZeneca promotional ...

This article has been written and funded by the Boehringer Ingelheim & Lilly Alliance (Alliance) for UK and Irish healthcare professionals. Alliance products will be discussed at this meeting. The All ...

Join us on Friday 11th October 2024 – 12:00-14:00 This webinar will explore cutting-edge clinical advances and national guidelines for cardiovascular, renal, and metabolic diseases.

Are you passionate about advancing your knowledge in skin health and wound healing? Do you want to stay on top of the latest innovations, research, and techniques in the field? If so, we would love yo ...

Diabetes UK has issued a statement in response to Lord Ara Darzi’s independent report on the current state of the NHS.

The new frontier of type 2 diabetes medicines has been made simple by a Leicester researcher, who has produced a graphic which plots 19 ongoing studies and their outcomes. The explanatory graphic has  ...